Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-04-16Clinical Trial Update: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension. [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating ambrisentan for pulmonary arterial hypertension has completed; the u…
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease [Phase 3]
A Phase 3 clinical trial evaluating bosentan for exercise-induced pulmonary arterial hypertension in patients with connective tissue disease…
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia [Phase 1]
Phase 1 trial evaluating safety and pharmacodynamic effects of bosentan (Tracleer) in patients with pulmonary arterial hypertension caused b…
-
CLINICAL_TRIALS trial_result · 2008-06-30Clinical Trial Update: Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension [Phase 1]
A Phase 1 clinical trial evaluating a combination of spironolactone, captopril, and carvedilol for pulmonary arterial hypertension has compl…
-
CLINICAL_TRIALS trial_result · 2008-06-26Clinical Trial Update: Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids. [Phase 4]
Phase 4 clinical trial evaluating long-acting phosphodiesterase-5 inhibitors as add-on therapy for patients with pulmonary arterial hyperten…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: Bosentan in Treatment of Pulmonary Arterial Hypertension [Phase 4]
Phase 4 clinical trial update on bosentan for pulmonary arterial hypertension. The study involving Eisenmenger syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-21Clinical Trial Update: PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension [Phase 3]
Phase 3 PHIRST-1 trial evaluating tadalafil for pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-12Clinical Trial Update: Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction [Phase 4]
Phase 4 study evaluating safety, efficacy and treatment satisfaction when transitioning PAH patients from Ventavis (iloprost) to IV Remoduli…
-
CLINICAL_TRIALS trial_result · 2007-11-09Clinical Trial Update: Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension [Phase 3]
Clinical trial update announcing the completion of a Phase 3 safety and efficacy study of sitaxentan (Thelin) in pulmonary arterial hyperten…
-
CLINICAL_TRIALS trial_result · 2007-06-07Clinical Trial Update: Hemodynamic Response After Six Months of Sildenafil [Phase 4]
This document provides an update on a Phase 4 clinical trial of sildenafil for pulmonary arterial hypertension. It focuses on hemodynamic re…